Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, ...

Uplizna (inebilizumab-cdon) is a prescription drug approved to treat certain autoimmune disorders. Uplizna comes as a solution for intravenous (IV) infusion into a vein. Specifically, Uplizna is used ...

Magic Leap creates ‘mixed reality’ goggles and hardware, intended to rival Apple’s Vision Pro and Meta’s Quest Saudi Arabia has ploughed more than $1bn (£744m) into a technology firm developing ...

Genmab A/S today announced that more than 20 abstracts evaluating epcoritamab-bysp, a T-cell engaging bispecific antibody administered subcutaneously, across lines of therapy and B-cell non-Hodgkin's ...

In a new Roadmap Report, 33 CIOs and CTOs share their challenges and insights on getting the data right, for the right use cases. The importance and value of data has never been clearer. But given the ...

MUMBAI: Dutch investor Prosus has picked up a 10.1% stake in Ixigo parent Le Travenues Technology for $146 million (Rs 1,296 crore), marking its first investment in a listed company, an exchange ...

Truxima is a biosimilar version of the brand-name drug Rituxan. Biosimilars tend to be less expensive than their brand-name versions. Doctors prescribe Truxima to treat conditions such as rheumatoid ...

Ford is re-evaluating its Maraimalai Nagar plant's future near Chennai, with top executives set to decide its fate. US tariffs have prompted a strategic rethink, potentially leading to either writing ...

The Alberta Teachers’ Association will not decide on how it will react to the province’s back-to-work legislation until it sees the exact wording of it. Bill 2, the Back to School Act, is expected to ...

State-owned life insurance giant, Life Insurance Corporation of India (LIC) on Saturday denied the Washington Post's allegations and said that the claims made by the newspaper were false, baseless and ...